Difficulty: Medium
Average Score: 92%
Practice
In a person suffering from hepatic disease, the dose of pethidine should be
Correct answer
B
Rationale
In a person suffering from hepatic disease, the correct dose adjustment for pethidine is to reduce it because the clearance of the drug is reduced. The liver plays a crucial role in metabolizing drugs, and hepatic impairment can lead to decreased drug metabolism and elimination. Pethidine, also known as meperidine, is primarily metabolized in the liver to its active metabolite, normeperidine. In hepatic disease, the impaired liver function can result in a decreased clearance of pethidine, leading to potential drug accumulation and increased risk of adverse effects.
Option A is incorrect because idiosyncratic reactions are unpredictable and not specifically related to hepatic disease. Option C is incorrect because in hepatic disease, the clearance of drugs is typically decreased, not increased. Option D is incorrect as the development of resistance to pethidine is not a typical consequence of hepatic disease but rather a pharmacological consideration.
Educationally, this question highlights the importance of considering dosage adjustments in patients with hepatic disease due to alterations in drug metabolism and clearance. It emphasizes the need for healthcare professionals to be knowledgeable about pharmacokinetic principles to ensure safe and effective drug therapy in patients with hepatic impairment. Understanding these concepts is vital in clinical practice to prevent drug-related complications and optimize patient outcomes.
Option A is incorrect because idiosyncratic reactions are unpredictable and not specifically related to hepatic disease. Option C is incorrect because in hepatic disease, the clearance of drugs is typically decreased, not increased. Option D is incorrect as the development of resistance to pethidine is not a typical consequence of hepatic disease but rather a pharmacological consideration.
Educationally, this question highlights the importance of considering dosage adjustments in patients with hepatic disease due to alterations in drug metabolism and clearance. It emphasizes the need for healthcare professionals to be knowledgeable about pharmacokinetic principles to ensure safe and effective drug therapy in patients with hepatic impairment. Understanding these concepts is vital in clinical practice to prevent drug-related complications and optimize patient outcomes.